Classification of Epithelial Malignant Tumors-the Differentiation Between Adenocarcinomas and Neuroendocrine Carcinomas: Why Rely on Nonspecific Histochemistry and Dismiss Specific Methods Like Immunohistochemistry and In Situ Hybridization?

Appl Immunohistochem Mol Morphol. 2016 May-Jun;24(5):309-12. doi: 10.1097/PAI.0000000000000190.

Authors

Helge L Waldum¹, Øystein F Sørdal

Affiliation

¹ *Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology †Department of Medicine, St Olavs Hospital, Trondheim, Norway.

PMID: 26067134
DOI: 10.1097/PAI.0000000000000190

No abstract available

Publication types

Editorial

MeSH terms

Adenocarcinoma / diagnosis*
Adenocarcinoma / genetics
Adenocarcinoma / pathology
Biomarkers, Tumor / genetics*
Carcinoma, Neuroendocrine / diagnosis*
Carcinoma, Neuroendocrine / genetics
Carcinoma, Neuroendocrine / pathology
Diagnosis, Differential
Humans
Immunohistochemistry / methods
In Situ Hybridization / methods
Neoplasms, Glandular and Epithelial / diagnosis*
Neoplasms, Glandular and Epithelial / genetics
Neoplasms, Glandular and Epithelial / pathology
Neuroendocrine Tumors / diagnosis*
Neuroendocrine Tumors / genetics
Neuroendocrine Tumors / pathology
Terminology as Topic

Substances

Biomarkers, Tumor